SciBase Files FDA 510(k) to Expand Nevisense Use for Non-Melanoma Skin Cancer

Jul 1, 2026
SciBase has submitted a 510(k) premarket notification to the U.S. FDA to expand the use of its AI device Nevisense to include non-melanoma skin cancers, aiming to broaden its clinical application beyond melanoma.

SciBase has announced in a press release the submission of a 510(k) premarket notification to the U.S. Food and Drug Administration seeking to expand the indication of its AI-powered dermatology device Nevisense. The company aims to include the assessment of non-melanoma skin cancers, also known as keratinocyte skin cancers, within the device’s approved uses.

Nevisense is currently the only FDA-approved AI technology for the assessment and early detection of melanoma. If cleared, the expanded indication would allow clinicians to use the same platform for evaluating lesions with characteristics of basal cell carcinoma and squamous cell carcinoma, which together represent the most common form of cancer in the United States.

In Europe, Nevisense already carries CE marking for both melanoma and keratinocyte skin cancer. SciBase stated that this submission marks a key step in its strategy to extend the clinical application of its diagnostic technology in the U.S. market.

We hope you enjoyed this article

Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.

Also, consider following us on social media:

Healthcare & Life Sciences AI AI Brief AI Brief (X)
Free newsletter

Life AI Weekly

Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.

AI Token Webinar

Whitepaper

Tensordyne Napier: What If One Rack Could Do the Work of Nine?

Tensordyne

This Tensordyne whitepaper presents Napier, an inference-focused AI processor and rack-scale system based on the company’s TDN Math logarithmic number system. It examines infrastructure requirements for large mixture-of-experts and agentic models, compares major inference architecture approaches, and details the TDN AIP processor, TDN72 pod, TDN Link fabric, and Napier Ultra configuration. The paper reports simulation-based performance, cost, and accuracy-validation results, including Tensordyne’s projected comparison of one Napier rack with a nine-rack Nvidia Rubin plus Groq deployment; the chip is reported as taped out and in fabrication.

Read more

You may also like

Free, six days a week

Daily AI Brief: the AI news that matters, in your inbox.